{"effective_time":"20180219","id":"82a033fa-ef47-415e-a1df-4edc1ff40dc4","openfda":{},"package_label_principal_display_panel":["PACKAGE/LABEL PRINCIPAL DISPLAY PANEL SYMFI LO (efavirenz, lamivudine, and tenofovir disoproxil fumarate) Tablets 400 mg/300 mg/300 mg Carton Label"],"set_id":"82a033fa-ef47-415e-a1df-4edc1ff40dc4","spl_product_data_elements":["SYMFI LO Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate EFAVIRENZ EFAVIRENZ LAMIVUDINE LAMIVUDINE TENOFOVIR DISOPROXIL FUMARATE TENOFOVIR ANHYDROUS CROSCARMELLOSE SODIUM HYDROXYPROPYL CELLULOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POLYVINYL ALCOHOL, UNSPECIFIED SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE FERRIC OXIDE YELLOW white to off-white M;TLE"],"version":"1"}